211 related articles for article (PubMed ID: 33974487)
21. An intronic splice site alteration in combination with a large deletion affecting VPS13B (COH1) causes Cohen syndrome.
Boschann F; Fischer-Zirnsak B; Wienker TF; Holtgrewe M; Seelow D; Eichhorn B; Döhnert S; Fahsold R; Horn D; Graul-Neumann LM
Eur J Med Genet; 2020 Sep; 63(9):103973. PubMed ID: 32505691
[TBL] [Abstract][Full Text] [Related]
22. Carbonic Anhydrase Inhibitor with Topical NSAID Therapy to Manage Cystoid Macular Edema in a Case of Gyrate Atrophy.
Piozzi E; Alessi S; Santambrogio S; Cillino G; Mazza M; Iggui A; Cillino S
Eur J Ophthalmol; 2017 Nov; 27(6):e179-e183. PubMed ID: 28708224
[TBL] [Abstract][Full Text] [Related]
23. TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY.
Khojasteh H; Roohipoor R; Riazi-Esfahani H; Ghasempour M
Retin Cases Brief Rep; 2021 May; 15(3):306-309. PubMed ID: 30028788
[TBL] [Abstract][Full Text] [Related]
24. Functional Analysis of a Compound Heterozygous Mutation in the VPS13B Gene in a Chinese Pedigree with Cohen Syndrome.
Lou G; Ke Y; Zhang Y; Liangjie G; Shama SA; Qi N; Qin L; Liao S; Zhao Y
J Mol Neurosci; 2021 May; 71(5):943-952. PubMed ID: 33025479
[TBL] [Abstract][Full Text] [Related]
25. Whole Exome Sequencing Identifies a Novel Homozygous Duplication Mutation in the VPS13B Gene in an Indian Family with Cohen Syndrome.
Kaushik P; Mahajan N; Girimaji SC; Kumar A
J Mol Neurosci; 2020 Aug; 70(8):1225-1228. PubMed ID: 32170714
[TBL] [Abstract][Full Text] [Related]
26. A rare canonical splice-site variant in VPS13B causes attenuated Cohen syndrome.
Daich Varela M; Motta FL; Webster AR; Arno G
Ophthalmic Genet; 2022 Feb; 43(1):110-115. PubMed ID: 34425733
[TBL] [Abstract][Full Text] [Related]
27. Homozygosity mapping and whole exome sequencing provide exact diagnosis of Cohen syndrome in a Saudi family.
Hashmi JA; Fadhli F; Almatrafi A; Afzal S; Ramzan K; Thiele H; Nürnberg P; Basit S
Brain Dev; 2020 Sep; 42(8):587-593. PubMed ID: 32402540
[TBL] [Abstract][Full Text] [Related]
28. Macular cystoid spaces in patients with retinal dystrophy.
Lingao MD; Ganesh A; Karthikeyan AS; Al Zuhaibi S; Al-Hosni A; Al Khayat A; Capasso J; Trumler AA; Stroh E; Al Shekaili H; Cater JR; Levin AV
Ophthalmic Genet; 2016 Dec; 37(4):377-383. PubMed ID: 26894784
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the VPS13B Gene in Iranian Patients with Different Phenotypes of Cohen Syndrome.
Alipour N; Salehpour S; Tonekaboni SH; Rostami M; Bahari S; Yassaee V; Miryounesi M; Ghafouri-Fard S
J Mol Neurosci; 2020 Jan; 70(1):21-25. PubMed ID: 31444703
[TBL] [Abstract][Full Text] [Related]
30. A Novel VPS13B Mutation Identified by Whole-Exome Sequencing in Iranian Patients with Cohen Syndrome.
Karimzadeh MR; Omidi F; Sahebalzamani A; Saeidi K
J Mol Neurosci; 2021 Dec; 71(12):2566-2574. PubMed ID: 34041686
[TBL] [Abstract][Full Text] [Related]
31. Macular cysts in retinal dystrophy.
Ganesh A; Stroh E; Manayath GJ; Al-Zuhaibi S; Levin AV
Curr Opin Ophthalmol; 2011 Sep; 22(5):332-9. PubMed ID: 21730849
[TBL] [Abstract][Full Text] [Related]
32. First case report of Cohen syndrome in the Tunisian population caused by VPS13B mutations.
Rejeb I; Jilani H; Elaribi Y; Hizem S; Hila L; Zillahrdt JL; Chelly J; Benjemaa L
BMC Med Genet; 2017 Nov; 18(1):134. PubMed ID: 29149870
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series.
Durmaz Engin C; Ekinci UB; Selver A; Saatci AO
Turk J Ophthalmol; 2020 Mar; 50(1):44-49. PubMed ID: 32167263
[TBL] [Abstract][Full Text] [Related]
34. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
[TBL] [Abstract][Full Text] [Related]
35. Changing facial phenotype in Cohen syndrome: towards clues for an earlier diagnosis.
El Chehadeh-Djebbar S; Blair E; Holder-Espinasse M; Moncla A; Frances AM; Rio M; Debray FG; Rump P; Masurel-Paulet A; Gigot N; Callier P; Duplomb L; Aral B; Huet F; Thauvin-Robinet C; Faivre L
Eur J Hum Genet; 2013 Jul; 21(7):736-42. PubMed ID: 23188044
[TBL] [Abstract][Full Text] [Related]
36. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Fishman GA; Apushkin MA
Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
Liew G; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
[TBL] [Abstract][Full Text] [Related]
38. Cystoid macular changes on optical coherence tomography in a patient with maternally inherited diabetes and deafness (MIDD)-associated macular dystrophy.
Qian CX; Branham K; Khan N; Lundy SK; Heckenlively JR; Jayasundera T
Ophthalmic Genet; 2017; 38(5):467-472. PubMed ID: 28140742
[TBL] [Abstract][Full Text] [Related]
39. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
[TBL] [Abstract][Full Text] [Related]
40. Optical coherence tomography findings in Cohen syndrome.
Huang LC; Kelly JP; Cabrera MT; Olmos de Koo LC; Weiss AH; Herlihy EP
J AAPOS; 2020 Oct; 24(5):306-309. PubMed ID: 32919079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
